ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

75
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
31 Aug 2024 15:00

(Mostly) Asia-Pac M&A: Seven & I, Silverlake Axis, Shanghai Henlius, CPMC, Shinko Electric, Arvida

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
475 Views
Share
26 Aug 2024 09:29

Henlius (2696 HK): Was There Any Doubt?

The scrip option is here. Currently trading at a gross/annualised spread of 7.4%/16.2%, assuming mid-February payment. I'd get involved  here. I'd...

Logo
520 Views
Share
26 Aug 2024 08:55

Shanghai Henlius Biotech (2696.HK) - Privatization Has Taken a Positive Step Forward

Share Alternative is necessary to improve success rate of privatization, but there're risk behind. As  undervaluation of Henlius is difficult to...

Logo
586 Views
Share
26 Aug 2024 00:27

Merger Arb Mondays (26 Aug) - China TCM, Henlius, Canvest, GA Pack, Huafa, Tohokushinsha

This week, the highest gross spreads are HEC Pharma (109.7%), China TCM (12.7%), Canvest (11.9%), Malaysia Airports (7.8%), Capitol (7.4%), Henlius...

Logo
352 Views
Share
25 Aug 2024 06:16

Weekly Deals Digest (25 Aug) - Seven & I, Iriso, Fancl, Alps Logistics, China TCM, Henlius, GA Pack

Last week, notable developments occurred in Event-Driven (Seven & I, Iriso, Fancl, Alps Logistics, China TCM, Henlius, GA Pack, APM) and ECM (99...

Logo
357 Views
Share
x